Dr. McCarthy graduated from the Louisiana State University School of Medicine at New Orleans in 1989. She works in Spokane, WA and specializes in Pediatric Surgery. Dr. McCarthy is affiliated with Providence Holy Family Hospital, Providence Mount Carmel Hospital and Providence Sacred Heart Medical Center & Childrens Hospital.
Us Patents
Biomarkers For Monitoring Intervention Therapies For Diabetes
- Rahway NJ, US Sandra C. Souza - Jersey City NJ, US Hidehisa Asada - Washington Township NJ, US Yoshiaki Miura - Glen Rock NJ, US Taku Nakahara - West New York NJ, US Diane McCarthy - Warrington PA, US
International Classification:
G01N 33/96 H01J 49/16 H01J 49/34
US Classification:
250282
Abstract:
The use of N-linked glycosylation pattern of serum proteins as a biomarker for evaluating the efficacy of intervention therapies for diabetes is disclosed. As disclosed herein, changes in the N-linked glycosylation of total plasma proteins precedes and predicts the decrease in glycated hemoglobin (HbA1c) associated with successful treatment of diabetes. Therefore, measuring changes in N-linked glycosylation of total serum plasma proteins over time may be used as a biomarker to evaluate or access the efficacy of an intervention therapy for diabetes.
Optimer Pharmaceuticals, Inc Nonclassifiable Establishments · Mfg of Pharmaceutical Preparations · Mfg Pharmaceutical Preparations & Commercial Biotechnical Research · Pharmaceutical Preparations · Mfg Pharmaceutical Preparations · Research & Development in Biotechnology · Biotechnology Products & Servi
65 Hayden Ave, Lexington, MA 02421 4755 Nekus Ctr Dr, San Diego, CA 92121 4755 Nexus Ctr Dr, San Diego, CA 92121 101 Hudson St #3501, Jersey City, NJ 07302 (858)9090736, (858)9090737